If anything, anti-GARP:TGF-β1 mAbs tend to protect Il22r−/− mice against severe intestinal disease and mortality induced by C. rodentium infection, although differences by comparison to PBS controls were not always statistically significant (Fig. 1c, supplementary Fig. 1b, and Fig. 2a). This evidence concerns the gene IL22RA1 and intestinal disorder.